Medicine Man Technologies Inc has a consensus price target of $2.5, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Benchmark, and Benchmark on March 28, 2024, March 30, 2023, and December 14, 2021. With an average price target of $3.17 between Benchmark, Benchmark, and Benchmark, there's an implied 286.18% upside for Medicine Man Technologies Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/28/2024 | SHWZ | Buy Now | Medicine Man Technologies | $0.82 | 204.88% | Benchmark | Mike Hickey | $3 → $2.5 | Maintains | Buy | Get Alert |
03/30/2023 | SHWZ | Buy Now | Medicine Man Technologies | $0.82 | 265.85% | Benchmark | Mike Hickey | → $3 | Reiterates | → Buy | Get Alert |
12/14/2021 | SHWZ | Buy Now | Medicine Man Technologies | $0.82 | 387.8% | Benchmark | Mike Hickey | — | Initiates | → Buy | Get Alert |
The latest price target for Medicine Man Technologies (OTCQX: SHWZ) was reported by Benchmark on March 28, 2024. The analyst firm set a price target for $2.50 expecting SHWZ to rise to within 12 months (a possible 190.70% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Medicine Man Technologies (OTCQX: SHWZ) was provided by Benchmark, and Medicine Man Technologies maintained their buy rating.
There is no last upgrade for Medicine Man Technologies.
There is no last downgrade for Medicine Man Technologies.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicine Man Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicine Man Technologies was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.
While ratings are subjective and will change, the latest Medicine Man Technologies (SHWZ) rating was a maintained with a price target of $3.00 to $2.50. The current price Medicine Man Technologies (SHWZ) is trading at is $0.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.